Skip to content

Savara SVRA Shares (Diluted)

Shares (Diluted) at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
177.6M+16.5%
Innoviva, Inc. logo
Innoviva, Inc.INVA
84.8M+35.3%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
60.2M+11.3%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
21.5M+7.5%
Theravance Biopharma logo
Theravance BiopharmaTBPH
51.3M+3.2%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
31.5M+17.3%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+247%
Enterprise value$1.19B+235%
P/S4,648.7×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's shares (diluted)?
Savara (SVRA) reported shares (diluted) of 253.3M in Q1 2026.
How has Savara's shares (diluted) changed year-over-year?
Savara's shares (diluted) increased by 17.2% year-over-year, from 216.1M to 253.3M.
What is the long-term trend for Savara's shares (diluted)?
Over 4 years (2021 to 2025), Savara's shares (diluted) has grown at a 14.0% compound annual growth rate (CAGR), from 516M to 871.4M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.